Joint effect of platelet distribution width and stent surface area on major adverse cardiovascular events after percutaneous coronary intervention

被引:2
|
作者
Zhang, Xiaofeng [1 ,2 ]
Ge, Haiyan [3 ]
Gong, Xiaoxuan [1 ]
Wang, Jing [1 ]
Li, Chunjian [1 ]
机构
[1] Nanjing Med Univ, Dept Cardiol, Affiliated Hosp 1, Nanjing, Peoples R China
[2] Nanjing Univ Chinese Med, Hosp Nanjing 2, Nanjing, Peoples R China
[3] Zhongshan Rehabil Hosp Jiangsu Prov, Dept Ultrasound, Nanjing, Peoples R China
关键词
Stent surface area(SSA); platelet distribution width (PDW); percutaneous coronary intervention (PCI); major adverse cardiovascular events (MACEs); DRUG-ELUTING STENTS; BARE METAL STENTS; ARTERY-DISEASE; MARKER; RISK;
D O I
10.21037/apm-21-1088
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: This study was conducted to analyze the influences of stent surface area (SSA), platelet distribution width (PDW), and the joint effect of these 2 risk factors on major adverse cardiovascular events (MACEs) in patients treated with percutaneous coronary intervention (PCI) together with drug-eluting stent (DES) implantation. Methods: Based on a cross-sectional survey conducted between 2011 and 2012, a prospective cohort study was enrolled consiting of 442 patients who had undergone PCI with DES implantation. We categorized the participants into 4 subgroups according to PDW and SSA. Cox proportional hazards models were applied to explore the correlation of PDW and SSA with MACE incidence. Results: During the 12 months of follow-up time, 87 patients experienced MACEs, which included 4 deaths (4.6%), 5 nonfatal myocardial infarctions (MIs) (5.75%), 9 ischemic strokes (10.34%), and 73 clinically relevant bleeding episodes (83.91%). The risks of MACEs were decreased by SSA and increased by PDW. However, the association of PDW or SSA with MACE was not statistically significant. Compared with the patients with PDW >= 13.5% and SSA <358.14 mm(2), the multivariable adjusted hazard ratios [HRs; 95% confience interval (CI)] of the total MACEs for the patients with PDW <13.5% and SSA >= 358.14 mm(2), and with PDW >= 13.5% and SSA >= 358.14 mm(2) were 0.94 (95% CI: 0.55-1.64) and 0.37 (95% CI: 0.18-0.76), respectively. Additionally, the patients in the group of PDW <13.5% and SSA <358.14 mm(2), and PDW >= 13.5% and SSA >= 358.14 mm(2) had respective HRs of 0.47 (95% CI: 0.24-0.91) and 0.28 (95% CI: 0.13-0.63) for 12-month bleeding events when PDW >= 13.5% and SSA <358.14 mm(2)was used as a group reference. Conclusions: Our present results suggest that the joint effect of PDW and SSA was significantly correlated to MACE development in the patients treated with PCI (with DES implantation).
引用
收藏
页码:5633 / 5640
页数:8
相关论文
共 50 条
  • [31] Association of serum cystatin C level and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Xiao, Zhibin
    Riletu, Aoge
    Yan, Xiaoyu
    Meng, Qi
    Zhang, Weiru
    Zhang, Na
    Ma, Chi
    Guo, Xin
    Han, Jiatong
    Nie, Huijuan
    Deng, Hui
    Liu, Jing
    Chen, Jianping
    Dong, Yu
    Liu, Tianlong
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2024, 14 (04) : 621 - 629
  • [32] Symptoms of Disturbed Sleep Predict Major Adverse Cardiac Events After Percutaneous Coronary Intervention
    Fernandes, Nisha M.
    Nield, Lynne E.
    Popel, Najla
    Cantor, Warren J.
    Plante, Sylvain
    Goldman, Lorne
    Prabhakar, Manu
    Manlhiot, Cedric
    McCrindle, Brian W.
    Miner, Steven E. S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (01) : 118 - 124
  • [33] Scores to Predict Early Major Adverse Cardiac Events After Primary Percutaneous Coronary Intervention
    Quang Ngoc Nguyen
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S11 - S11
  • [34] Incidence of Major Adverse Cardiovascular Events After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Multicenter Registry
    Danek, Barbara A.
    Karatasakis, Aris
    Doing, Anthony
    Dattilo, Philip
    Nguyen-Trong, Phuong-Khanh J.
    Karacsonyi, Judit
    Alame, Aya
    Resendes, Erica
    Kalsaria, Pratik
    Rangan, Bavana
    Roesle, Michele
    Thompson, Craig
    Banerjee, Subhash
    Brilakis, Emmanouil
    CIRCULATION, 2016, 134
  • [35] The relationship between low thiol levels and major adverse cardiovascular events after primary percutaneous coronary intervention in patients with STEMI
    Akkus, Oguz
    Topuz, Mustafa
    Koca, Hasan
    Harbalioglu, Hazar
    Kaypakli, Onur
    Kaplan, Mehmet
    Sen, Omer
    Bulut, Atilla
    Celik, Hakim
    Erel, Ozcan
    Gur, Mustafa
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2018, 46 (04): : 248 - 259
  • [36] Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention
    Sud, Maneesh
    Han, Lu
    Koh, Maria
    Abdel-Qadir, Husam
    Austin, Peter C.
    Farkouh, Michael E.
    Godoy, Lucas C.
    Lawler, Patrick R.
    Udell, Jacob A.
    Wijeysundera, Harindra C.
    Ko, Dennis T.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (12) : 1440 - 1450
  • [37] Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
    Cai, Anping
    Dillon, Chrisly
    Hillegass, William B.
    Beasley, Mark
    Brott, Brigitta C.
    Bittner, Vera A.
    Perry, Gilbert J.
    Halade, Ganesh V.
    Prabhu, Sumanth D.
    Limdi, Nita A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
  • [38] Effectiveness of Ticagrelor Compared to Clopidogrel in Reducing the Risk of Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease After Percutaneous Coronary Intervention
    Nur'amin, Hendra Wana
    Dwiprahasto, Iwan
    Kristin, Erna
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 567 - 567
  • [39] The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention for Five Years
    Du, Jinling
    Zhang, Danyang
    Yin, Yue
    Zhang, Xiaofei
    Li, Jifu
    Liu, Dexiang
    Pan, Fang
    Chen, Wenqiang
    MEDICINE, 2016, 95 (15)
  • [40] Gender is Not a Predictor of Mortality or Major Adverse Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes
    Josiah, Angeline
    Farshid, Ahmad
    HEART LUNG AND CIRCULATION, 2019, 28 (05): : 727 - 734